Non-Insulin-Dependent Diabetes Mellitus Duration | Antidiabetics Oral Absent
Item
patients with t2dm, diagnosed at least 6 weeks prior to visit 1, who have had no treatment with oral antidiabetic agents for at least 12 weeks prior to study entry (visit 1) and no treatment with oral antidiabetic agents at any time in the past for > 3 consecutive months
boolean
C0011860 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Age
Item
>/= 18 years
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
body mass index in the range of 22-35 kg/m2
boolean
C1305855 (UMLS CUI [1])
Glycosylated hemoglobin A Percentage
Item
hba1c </=7.5%
boolean
C0019018 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Complication Diabetic Metabolic
Item
acute metabolic diabetic complications
boolean
C0342257 (UMLS CUI [1,1])
C0311400 (UMLS CUI [1,2])
Complications of Diabetes Mellitus Evidence
Item
evidence of significant diabetic complications
boolean
C0342257 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
Insulin regime
Item
insulin treatment within the past 6 months
boolean
C0557978 (UMLS CUI [1])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])